Paul S. Mischel is a neuropathologist and cancer biologist who has served on the UCLA School of Medicine Faculty since joining the Department of Pathology and Laboratory Medicine in 1998. He became an associate professor in 2004. Dr. Mischel graduated with a B.A. in Philosophy from the University of Pennsylvania in 1984. He earned his M.D. from Cornell University Medical College in 1991, graduating with Alpha Omega Alpha Honors. He did his residency training in Anatomic Pathology and his fellowship in Neuropathology at UCLA.

Judith Gasson, Ph.D., became the director of UCLA's Jonsson Comprehensive Cancer Center on Sept. 15, 1995. She is a molecular biologist and is responsible for one of only 39 institutions designated as comprehensive cancer centers by the National Cancer Institute.

Tom Graeber, PhD is faculty in the Department of Molecular and Medical Pharmacology and a member of the Crump Institute for Molecular Imaging at UCLA, and is a National Human Genome Research Institute (NHGRI) Genome Scholar. His background includes physics, cancer biology, signal transduction, computational biology and proteomics, and he is now building experimental and computational approaches to studying cancer signaling from a systems perspective

Dr. Jeff Ranish joined the ISB faculty in 2005. He has a strong background in the disciplines of proteomics, molecular biology and biochemistry. He has a longstanding interest in understanding how protein’s function in the context of biological systems. Dr. Ranish pursues this goal by developing and applying state of the art proteomics technologies to probe the composition of macromolecular complexes, with a focus on transcriptional regulatory complexes.

Dr. Antoni Ribas and his colleagues are conducting studies aimed at understanding how the immune system can be effectively used to treat cancer. The work is focused on the ability to activate killer immune lymphocytes specifically targeted to the cancer.

Hsian-Rong Tseng's research interests are to develop microfluidic technology and to utilize this technology to address important issues in the fields of molecular imaging, cancer biology and chemistry.

Ilya Shmulevich received his Ph.D. degree in Electrical and Computer Engineering from Purdue University, West Lafayette, IN, USA, in 1997.  In 1997-1998, he was a postdoctoral researcher at the Nijmegen Institute for Cognition and Information at the University of Nijmegen and National Research Institute for Mathematics and Computer Science at the University of Amsterdam in The Netherlands, where he studied computational models of music perception and recognition. 

Bio for Biaoyang Lin, Ph.D.

Owen Witte received his undergraduate degree from Cornell and his MD from Stanford University where he trained with Irv Weissman. He completed postdoctoral research at MIT in the laboratory of David Baltimore. In 1980 he joined the faculty at UCLA where he presently is an Investigator of the Howard Hughes Medical Institute, Professor of Microbiology, Immunology and Molecular Genetics where he holds the President's Chair in Developmental Immunology, and Professor of Molecular and Medical Pharmacology at the David Geffen School of Medicine at UCLA.

Dr. Charles Sawyers is Professor of Medicine, Molecular Pharmacology and Urology at the University of California Los Angeles and an Investigator of the Howard Hughes Medical Institute. Dr. Sawyers obtained his MD at Johns Hopkins, did his housestaff training in Internal Medicine at University of California San Francisco and completed his hematology-oncology fellowship training at UCLA. Dr. Sawyers’ laboratory is focused on characterizing signal transduction pathway abnormalities in various cancers, including chronic myeloid leukemia, prostate cancer and glioblastoma, with an eye toward translational implications.